Skip to main content

Abiraterone Acetate

NDC 75907-224 · Dr. Reddys Laboratories Inc

Generic nameAbiraterone Acetate
Dosage formTABLET
RouteORAL
Active ingredient(s)ABIRATERONE ACETATE
Strength250 mg/1
Pharmacologic classCytochrome P450 17A1 Inhibitor [EPC], Cytochrome P450 17A1 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA]
Marketing categoryANDA

Packages

75907-224-04 — 120 TABLET in 1 BOTTLE (75907-224-04)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

68001-673 — Abiraterone Acetate, 68462-135 — abiraterone acetate, 68462-882 — abiraterone acetate, 69238-1165 — Abiraterone, 69238-1754 — ABIRATERONE, 71921-177 — Abiraterone acetate, 71921-178 — abiraterone acetate, 72162-2151 — abiraterone acetate, 72205-030 — Abiraterone acetate, 72205-284 — Abiraterone acetate, 72205-285 — Abiraterone acetate, 72603-110 — abiraterone acetate, 72603-111 — abiraterone acetate, 72789-213 — Abiraterone acetate, 82009-139 — Abiraterone acetate, 82009-140 — Abiraterone acetate, 82249-010 — Abiraterone acetate, 82249-011 — Abiraterone acetate, 82293-001 — abiraterone acetate, 82293-002 — abiraterone acetate, +24 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels